These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 30130562)

  • 1. Tat-Src reduced NR2B tyrosine phosphorylation and its interaction with NR2B in levodopa-induced dyskinetic rats model.
    Ba M; Yu G; Yang H; Wang Y; Yu L; Kong M
    Behav Brain Res; 2019 Jan; 356():41-45. PubMed ID: 30130562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S-nitrosylation of Src by NR2B-nNOS signal causes Src activation and NR2B tyrosine phosphorylation in levodopa-induced dyskinetic rat model.
    Ba M; Ding W; Guan L; Lv Y; Kong M
    Hum Exp Toxicol; 2019 Mar; 38(3):303-310. PubMed ID: 30350722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postsynaptic density protein 95-regulated NR2B tyrosine phosphorylation and interactions of Fyn with NR2B in levodopa-induced dyskinesia rat models.
    Ba M; Kong M; Ma G
    Drug Des Devel Ther; 2015; 9():199-206. PubMed ID: 25565773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NR2B antagonist CP-101,606 inhibits NR2B phosphorylation at tyrosine-1472 and its interactions with Fyn in levodopa-induced dyskinesia rat model.
    Kong M; Ba M; Liu C; Zhang Y; Zhang H; Qiu H
    Behav Brain Res; 2015 Apr; 282():46-53. PubMed ID: 25576965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repetitive transcranial magnetic stimulation (rTMS) improves behavioral and biochemical deficits in levodopa-induced dyskinetic rats model.
    Ba M; Kong M; Guan L; Yi M; Zhang H
    Oncotarget; 2016 Sep; 7(37):58802-58812. PubMed ID: 27613848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A critical interaction between NR2B and MAGUK in L-DOPA induced dyskinesia.
    Gardoni F; Picconi B; Ghiglieri V; Polli F; Bagetta V; Bernardi G; Cattabeni F; Di Luca M; Calabresi P
    J Neurosci; 2006 Mar; 26(11):2914-22. PubMed ID: 16540568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the D1-N-methyl-D-aspartate receptor complex reduces L-dopa-induced dyskinesia in 6-hydroxydopamine-lesioned Parkinson's rats.
    Song L; Zhang Z; Hu R; Cheng J; Li L; Fan Q; Wu N; Gan J; Zhou M; Liu Z
    Drug Des Devel Ther; 2016; 10():547-55. PubMed ID: 26893543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NMDA receptor regulation of levodopa-induced behavior and changes in striatal G protein-coupled receptor kinase 6 and β-arrestin-1 expression in parkinsonian rats.
    Wu N; Song L; Yang X; Yuan W; Liu Z
    Clin Interv Aging; 2013; 8():347-52. PubMed ID: 23569367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of synaptic D1 dopamine/N-methyl-D-aspartate glutamate receptor complexes in L-DOPA-induced dyskinesia in the rat.
    Fiorentini C; Rizzetti MC; Busi C; Bontempi S; Collo G; Spano P; Missale C
    Mol Pharmacol; 2006 Mar; 69(3):805-12. PubMed ID: 16365282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of Pleiotrophin and Fyn in the striatum of rats undergoing L-DOPA-induced dyskinesia.
    Gomez G; Saborido MD; Bernardi MA; Gershanik OS; Taravini IR; Ferrario JE
    Neurosci Lett; 2018 Feb; 666():5-10. PubMed ID: 29241709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Kinase Fyn As a Novel Intermediate in L-DOPA-Induced Dyskinesia in Parkinson's Disease.
    Sanz-Blasco S; Bordone MP; Damianich A; Gomez G; Bernardi MA; Isaja L; Taravini IR; Hanger DP; Avale ME; Gershanik OS; Ferrario JE
    Mol Neurobiol; 2018 Jun; 55(6):5125-5136. PubMed ID: 28840468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson's disease.
    Pinna A; Ko WK; Costa G; Tronci E; Fidalgo C; Simola N; Li Q; Tabrizi MA; Bezard E; Carta M; Morelli M
    Mov Disord; 2016 Apr; 31(4):501-11. PubMed ID: 26871939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arcuate Src activation-induced phosphorylation of NR2B NMDA subunit contributes to inflammatory pain in rats.
    Xu L; Pan Y; Zhu Q; Gong S; Tao J; Xu GY; Jiang X
    J Neurophysiol; 2012 Dec; 108(11):3024-33. PubMed ID: 22993256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of L-DOPA and STN-HFS dyskinesiogenic treatments on NR2B regulation in basal ganglia in the rat model of Parkinson's disease.
    Quintana A; Sgambato-Faure V; Savasta M
    Neurobiol Dis; 2012 Dec; 48(3):379-90. PubMed ID: 22759925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in glutamate receptors in dyskinetic parkinsonian monkeys after unilateral subthalamotomy.
    Jourdain VA; Morin N; Grégoire L; Morissette M; Di Paolo T
    J Neurosurg; 2015 Dec; 123(6):1383-93. PubMed ID: 25932606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in subunit expression, composition, and phosphorylation of striatal N-methyl-D-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson's disease.
    Dunah AW; Wang Y; Yasuda RP; Kameyama K; Huganir RL; Wolfe BB; Standaert DG
    Mol Pharmacol; 2000 Feb; 57(2):342-52. PubMed ID: 10648644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative splicing of AMPA receptor subunits in the 6-OHDA-lesioned rat model of Parkinson's disease and L-DOPA-induced dyskinesia.
    Kobylecki C; Crossman AR; Ravenscroft P
    Exp Neurol; 2013 Sep; 247():476-84. PubMed ID: 23360800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher free D-aspartate and N-methyl-D-aspartate levels prevent striatal depotentiation and anticipate L-DOPA-induced dyskinesia.
    Errico F; Bonito-Oliva A; Bagetta V; Vitucci D; Romano R; Zianni E; Napolitano F; Marinucci S; Di Luca M; Calabresi P; Fisone G; Carta M; Picconi B; Gardoni F; Usiello A
    Exp Neurol; 2011 Dec; 232(2):240-50. PubMed ID: 21946266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rabphilin 3A: A novel target for the treatment of levodopa-induced dyskinesias.
    Stanic J; Mellone M; Napolitano F; Racca C; Zianni E; Minocci D; Ghiglieri V; Thiolat ML; Li Q; Longhi A; De Rosa A; Picconi B; Bezard E; Calabresi P; Di Luca M; Usiello A; Gardoni F
    Neurobiol Dis; 2017 Dec; 108():54-64. PubMed ID: 28823933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EphrinB2 induces pelvic-urethra reflex potentiation via Src kinase-dependent tyrosine phosphorylation of NR2B.
    Wu HC; Chang CH; Peng HY; Chen GD; Lai CY; Hsieh MC; Lin TB
    Am J Physiol Renal Physiol; 2011 Feb; 300(2):F403-11. PubMed ID: 21147838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.